Syros Pharmaceuticals, Inc. (SYRS)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2016 - 2018
Gene Control Medicines	9.94M	Log In	Log In	Log In	Log In	Upgrade
Gene Control Medicines Growth	-33.23%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2016 - 2018
United States	9.94M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-33.23%	Log In	Log In	Log In	Log In	Upgrade